nodes	percent_of_prediction	percent_of_DWPC	metapath
Clozapine—HRH1—atherosclerosis	0.42	1	CbGaD
Clozapine—CYP2C8—Simvastatin—atherosclerosis	0.0245	0.0632	CbGbCtD
Clozapine—CYP2C8—Lovastatin—atherosclerosis	0.024	0.0618	CbGbCtD
Clozapine—CYP2C8—Pravastatin—atherosclerosis	0.024	0.0618	CbGbCtD
Clozapine—CYP2C19—Rosuvastatin—atherosclerosis	0.0221	0.057	CbGbCtD
Clozapine—CYP2C19—Simvastatin—atherosclerosis	0.0205	0.053	CbGbCtD
Clozapine—CYP2C19—Lovastatin—atherosclerosis	0.0201	0.0519	CbGbCtD
Clozapine—CYP2D6—Niacin—atherosclerosis	0.0198	0.051	CbGbCtD
Clozapine—CYP2C9—Rosuvastatin—atherosclerosis	0.0184	0.0474	CbGbCtD
Clozapine—ABCB1—Ezetimibe—atherosclerosis	0.0178	0.046	CbGbCtD
Clozapine—CYP2C9—Simvastatin—atherosclerosis	0.0171	0.0441	CbGbCtD
Clozapine—CYP2C9—Pravastatin—atherosclerosis	0.0167	0.0431	CbGbCtD
Clozapine—CYP2C9—Lovastatin—atherosclerosis	0.0167	0.0431	CbGbCtD
Clozapine—ABCB1—Simvastatin—atherosclerosis	0.0166	0.0428	CbGbCtD
Clozapine—ABCB1—Lovastatin—atherosclerosis	0.0162	0.0419	CbGbCtD
Clozapine—ABCB1—Pravastatin—atherosclerosis	0.0162	0.0419	CbGbCtD
Clozapine—CYP2D6—Simvastatin—atherosclerosis	0.0156	0.0403	CbGbCtD
Clozapine—CYP2D6—Pravastatin—atherosclerosis	0.0153	0.0394	CbGbCtD
Clozapine—CYP2D6—Lovastatin—atherosclerosis	0.0153	0.0394	CbGbCtD
Clozapine—CYP3A4—Rosuvastatin—atherosclerosis	0.0107	0.0276	CbGbCtD
Clozapine—CYP3A4—Ezetimibe—atherosclerosis	0.0107	0.0276	CbGbCtD
Clozapine—CYP3A4—Simvastatin—atherosclerosis	0.00993	0.0256	CbGbCtD
Clozapine—CYP3A4—Pravastatin—atherosclerosis	0.00972	0.0251	CbGbCtD
Clozapine—CYP3A4—Lovastatin—atherosclerosis	0.00972	0.0251	CbGbCtD
Clozapine—HTR2A—arteriole—atherosclerosis	0.00254	0.078	CbGeAlD
Clozapine—HTR7—vein—atherosclerosis	0.00243	0.0746	CbGeAlD
Clozapine—HTR2A—vein—atherosclerosis	0.00152	0.0465	CbGeAlD
Clozapine—HTR1B—artery—atherosclerosis	0.00128	0.0394	CbGeAlD
Clozapine—HTR1D—artery—atherosclerosis	0.00124	0.0381	CbGeAlD
Clozapine—HTR2A—hindlimb—atherosclerosis	0.00101	0.0309	CbGeAlD
Clozapine—HTR1B—blood vessel—atherosclerosis	0.001	0.0307	CbGeAlD
Clozapine—HTR7—artery—atherosclerosis	0.00099	0.0304	CbGeAlD
Clozapine—HTR1D—blood vessel—atherosclerosis	0.000968	0.0297	CbGeAlD
Clozapine—HTR2A—appendage—atherosclerosis	0.000864	0.0265	CbGeAlD
Clozapine—HTR7—endothelium—atherosclerosis	0.000836	0.0257	CbGeAlD
Clozapine—HTR7—blood vessel—atherosclerosis	0.000771	0.0237	CbGeAlD
Clozapine—Azatadine—HRH1—atherosclerosis	0.000755	0.133	CrCbGaD
Clozapine—Chlorcyclizine—HRH1—atherosclerosis	0.000745	0.131	CrCbGaD
Clozapine—FMO3—adipose tissue—atherosclerosis	0.00067	0.0206	CbGeAlD
Clozapine—UGT1A4—liver—atherosclerosis	0.000667	0.0205	CbGeAlD
Clozapine—H1F0—connective tissue—atherosclerosis	0.000641	0.0197	CbGeAlD
Clozapine—HTR2A—artery—atherosclerosis	0.000617	0.019	CbGeAlD
Clozapine—H1F0—cardiovascular system—atherosclerosis	0.000557	0.0171	CbGeAlD
Clozapine—HTR2A—endothelium—atherosclerosis	0.000521	0.016	CbGeAlD
Clozapine—HTR1D—connective tissue—atherosclerosis	0.000496	0.0152	CbGeAlD
Clozapine—H1F0—adipose tissue—atherosclerosis	0.000492	0.0151	CbGeAlD
Clozapine—HTR2A—blood vessel—atherosclerosis	0.000481	0.0148	CbGeAlD
Clozapine—FMO3—liver—atherosclerosis	0.00047	0.0144	CbGeAlD
Clozapine—CYP2A6—adipose tissue—atherosclerosis	0.000461	0.0141	CbGeAlD
Clozapine—HTR1B—cardiovascular system—atherosclerosis	0.000446	0.0137	CbGeAlD
Clozapine—CHRM2—cardiovascular system—atherosclerosis	0.000444	0.0136	CbGeAlD
Clozapine—CYP1B1—connective tissue—atherosclerosis	0.00044	0.0135	CbGeAlD
Clozapine—HTR1D—cardiovascular system—atherosclerosis	0.000432	0.0133	CbGeAlD
Clozapine—Cyclizine—HRH1—atherosclerosis	0.000426	0.0748	CrCbGaD
Clozapine—CHRM1—cardiovascular system—atherosclerosis	0.000404	0.0124	CbGeAlD
Clozapine—Ziprasidone—HRH1—atherosclerosis	0.000401	0.0704	CrCbGaD
Clozapine—HTR7—connective tissue—atherosclerosis	0.000395	0.0121	CbGeAlD
Clozapine—CYP1B1—cardiovascular system—atherosclerosis	0.000383	0.0118	CbGeAlD
Clozapine—Azelastine—HRH1—atherosclerosis	0.000376	0.066	CrCbGaD
Clozapine—HTR1A—cardiovascular system—atherosclerosis	0.00036	0.0111	CbGeAlD
Clozapine—H1F0—liver—atherosclerosis	0.000345	0.0106	CbGeAlD
Clozapine—HTR7—cardiovascular system—atherosclerosis	0.000344	0.0106	CbGeAlD
Clozapine—Zuclopenthixol—HRH1—atherosclerosis	0.000339	0.0595	CrCbGaD
Clozapine—CYP1B1—adipose tissue—atherosclerosis	0.000338	0.0104	CbGeAlD
Clozapine—Cyproheptadine—HRH1—atherosclerosis	0.000334	0.0585	CrCbGaD
Clozapine—ADRA1A—cardiovascular system—atherosclerosis	0.000332	0.0102	CbGeAlD
Clozapine—Olanzapine—HRH1—atherosclerosis	0.000323	0.0567	CrCbGaD
Clozapine—CYP2A6—liver—atherosclerosis	0.000323	0.00992	CbGeAlD
Clozapine—CHRM3—adipose tissue—atherosclerosis	0.000319	0.00978	CbGeAlD
Clozapine—ABCB1—blood vessel—atherosclerosis	0.000315	0.00967	CbGeAlD
Clozapine—Trazodone—HRH1—atherosclerosis	0.000312	0.0548	CrCbGaD
Clozapine—HRH1—connective tissue—atherosclerosis	0.000295	0.00906	CbGeAlD
Clozapine—Thiothixene—HRH1—atherosclerosis	0.000293	0.0513	CrCbGaD
Clozapine—ADRA1A—adipose tissue—atherosclerosis	0.000293	0.00898	CbGeAlD
Clozapine—ADRA2A—connective tissue—atherosclerosis	0.00029	0.0089	CbGeAlD
Clozapine—Prochlorperazine—HRH1—atherosclerosis	0.00028	0.0491	CrCbGaD
Clozapine—ADRA2C—adipose tissue—atherosclerosis	0.000279	0.00856	CbGeAlD
Clozapine—CYP2C9—cardiovascular system—atherosclerosis	0.00026	0.008	CbGeAlD
Clozapine—Amoxapine—HRH1—atherosclerosis	0.000257	0.0451	CrCbGaD
Clozapine—CYP2E1—cardiovascular system—atherosclerosis	0.000247	0.00758	CbGeAlD
Clozapine—HTR2A—connective tissue—atherosclerosis	0.000247	0.00757	CbGeAlD
Clozapine—CYP1A1—adipose tissue—atherosclerosis	0.000239	0.00733	CbGeAlD
Clozapine—CYP1B1—liver—atherosclerosis	0.000237	0.00727	CbGeAlD
Clozapine—HRH1—adipose tissue—atherosclerosis	0.000226	0.00695	CbGeAlD
Clozapine—ADRA2A—adipose tissue—atherosclerosis	0.000222	0.00683	CbGeAlD
Clozapine—HTR2A—cardiovascular system—atherosclerosis	0.000214	0.00659	CbGeAlD
Clozapine—HTR7—liver—atherosclerosis	0.000213	0.00653	CbGeAlD
Clozapine—CYP2C19—liver—atherosclerosis	0.000208	0.00638	CbGeAlD
Clozapine—ADRA1A—liver—atherosclerosis	0.000205	0.0063	CbGeAlD
Clozapine—Trifluoperazine—HRH1—atherosclerosis	0.000202	0.0355	CrCbGaD
Clozapine—Loxapine—HRH1—atherosclerosis	0.000201	0.0352	CrCbGaD
Clozapine—Quetiapine—HRH1—atherosclerosis	0.000196	0.0344	CrCbGaD
Clozapine—ADRA2C—liver—atherosclerosis	0.000196	0.006	CbGeAlD
Clozapine—CYP2C8—liver—atherosclerosis	0.000181	0.00557	CbGeAlD
Clozapine—CYP1A2—liver—atherosclerosis	0.00017	0.00521	CbGeAlD
Clozapine—CYP1A1—liver—atherosclerosis	0.000167	0.00514	CbGeAlD
Clozapine—CYP2C9—liver—atherosclerosis	0.000161	0.00494	CbGeAlD
Clozapine—CYP2E1—liver—atherosclerosis	0.000153	0.00469	CbGeAlD
Clozapine—ABCB1—cardiovascular system—atherosclerosis	0.000141	0.00432	CbGeAlD
Clozapine—HTR2A—liver—atherosclerosis	0.000133	0.00407	CbGeAlD
Clozapine—ABCB1—adipose tissue—atherosclerosis	0.000124	0.00381	CbGeAlD
Clozapine—CYP3A4—liver—atherosclerosis	0.000123	0.00377	CbGeAlD
Clozapine—CYP2D6—liver—atherosclerosis	0.000121	0.00371	CbGeAlD
Clozapine—ABCB1—liver—atherosclerosis	8.69e-05	0.00267	CbGeAlD
Clozapine—Clonazepam—ALB—atherosclerosis	7.7e-05	0.0135	CrCbGaD
Clozapine—Olanzapine—ALB—atherosclerosis	7.46e-05	0.0131	CrCbGaD
Clozapine—Thiothixene—ALB—atherosclerosis	6.76e-05	0.0119	CrCbGaD
Clozapine—Diazepam—ALB—atherosclerosis	3.94e-05	0.00692	CrCbGaD
Clozapine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	2.21e-06	1.43e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—CAV1—atherosclerosis	2.21e-06	1.43e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.21e-06	1.43e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.21e-06	1.43e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—APOA1—atherosclerosis	2.2e-06	1.43e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	2.19e-06	1.42e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.18e-06	1.41e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	2.18e-06	1.41e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	2.17e-06	1.41e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.17e-06	1.41e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	2.16e-06	1.4e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CD36—atherosclerosis	2.16e-06	1.4e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.15e-06	1.39e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—MAPK3—atherosclerosis	2.15e-06	1.39e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.15e-06	1.39e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—ALB—atherosclerosis	2.14e-06	1.39e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	2.14e-06	1.39e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.14e-06	1.39e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	2.13e-06	1.38e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	2.13e-06	1.38e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—PPARG—atherosclerosis	2.13e-06	1.38e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	2.13e-06	1.38e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	2.11e-06	1.37e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	2.11e-06	1.37e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	2.11e-06	1.36e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.1e-06	1.36e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	2.1e-06	1.36e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.1e-06	1.36e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	2.09e-06	1.35e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—INS—atherosclerosis	2.09e-06	1.35e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—TGFB1—atherosclerosis	2.09e-06	1.35e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	2.08e-06	1.35e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—PPARG—atherosclerosis	2.08e-06	1.35e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	2.08e-06	1.34e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	2.07e-06	1.34e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.07e-06	1.34e-05	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	2.07e-06	1.34e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	2.06e-06	1.34e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	2.05e-06	1.33e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—NOS3—atherosclerosis	2.05e-06	1.33e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—PTGS2—atherosclerosis	2.05e-06	1.33e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.05e-06	1.33e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	2.04e-06	1.32e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—INS—atherosclerosis	2.04e-06	1.32e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	2.04e-06	1.32e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—IL6—atherosclerosis	2.04e-06	1.32e-05	CbGpPWpGaD
Clozapine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	2.04e-06	1.32e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	2.03e-06	1.32e-05	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.03e-06	1.32e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.03e-06	1.31e-05	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	2.02e-06	1.31e-05	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	2.02e-06	1.31e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.01e-06	1.3e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.01e-06	1.3e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	2e-06	1.3e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—IL6—atherosclerosis	2e-06	1.3e-05	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2e-06	1.29e-05	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.99e-06	1.29e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	1.99e-06	1.29e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	1.99e-06	1.29e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.98e-06	1.28e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.97e-06	1.28e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	1.97e-06	1.27e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.96e-06	1.27e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.96e-06	1.27e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.96e-06	1.27e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.95e-06	1.26e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—AGT—atherosclerosis	1.94e-06	1.26e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	1.94e-06	1.26e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—PPARG—atherosclerosis	1.94e-06	1.26e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.94e-06	1.25e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—INS—atherosclerosis	1.92e-06	1.24e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.92e-06	1.24e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	1.92e-06	1.24e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	1.92e-06	1.24e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.92e-06	1.24e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—ALB—atherosclerosis	1.91e-06	1.24e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	1.91e-06	1.23e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—APOE—atherosclerosis	1.9e-06	1.23e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—INS—atherosclerosis	1.9e-06	1.23e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—MMP9—atherosclerosis	1.9e-06	1.23e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	1.9e-06	1.23e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	1.9e-06	1.23e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	1.89e-06	1.22e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—CAV1—atherosclerosis	1.89e-06	1.22e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.89e-06	1.22e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	1.89e-06	1.22e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.88e-06	1.22e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	1.88e-06	1.22e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—APOA1—atherosclerosis	1.88e-06	1.22e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	1.88e-06	1.22e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.88e-06	1.22e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.88e-06	1.22e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	1.88e-06	1.21e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.87e-06	1.21e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	1.87e-06	1.21e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	1.87e-06	1.21e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—ALB—atherosclerosis	1.87e-06	1.21e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.87e-06	1.21e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.87e-06	1.21e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	1.86e-06	1.21e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—IL6—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—IL6—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.85e-06	1.2e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	1.84e-06	1.19e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	1.84e-06	1.19e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	1.84e-06	1.19e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	1.84e-06	1.19e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—IL6—atherosclerosis	1.84e-06	1.19e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—APOB—atherosclerosis	1.84e-06	1.19e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	1.83e-06	1.19e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—NOS3—atherosclerosis	1.83e-06	1.19e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	1.82e-06	1.18e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	1.82e-06	1.18e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.82e-06	1.18e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	1.81e-06	1.18e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.81e-06	1.18e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	1.81e-06	1.17e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.81e-06	1.17e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	1.81e-06	1.17e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—IL6—atherosclerosis	1.8e-06	1.17e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—NOS3—atherosclerosis	1.79e-06	1.16e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.79e-06	1.16e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.78e-06	1.16e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—IL6—atherosclerosis	1.77e-06	1.15e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—ALB—atherosclerosis	1.76e-06	1.14e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	1.76e-06	1.14e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—LPL—atherosclerosis	1.75e-06	1.14e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—IL6—atherosclerosis	1.75e-06	1.13e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—ALB—atherosclerosis	1.75e-06	1.13e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.74e-06	1.13e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.73e-06	1.12e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.73e-06	1.12e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.72e-06	1.12e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.72e-06	1.11e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.72e-06	1.11e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.71e-06	1.11e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.71e-06	1.11e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.71e-06	1.11e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—AKT1—atherosclerosis	1.71e-06	1.11e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—AKT1—atherosclerosis	1.71e-06	1.1e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.7e-06	1.1e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.7e-06	1.1e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—AKT1—atherosclerosis	1.69e-06	1.1e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.69e-06	1.1e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.69e-06	1.1e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.69e-06	1.09e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.69e-06	1.09e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—NOS3—atherosclerosis	1.68e-06	1.09e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.68e-06	1.09e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.68e-06	1.09e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.68e-06	1.09e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.68e-06	1.09e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.67e-06	1.08e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.67e-06	1.08e-05	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—AKT1—atherosclerosis	1.67e-06	1.08e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—NOS3—atherosclerosis	1.67e-06	1.08e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CD36—atherosclerosis	1.67e-06	1.08e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.66e-06	1.08e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—AKT1—atherosclerosis	1.66e-06	1.07e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.66e-06	1.07e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—PPARG—atherosclerosis	1.66e-06	1.07e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.64e-06	1.07e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—PTGS2—atherosclerosis	1.63e-06	1.06e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—AKT1—atherosclerosis	1.63e-06	1.06e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—INS—atherosclerosis	1.63e-06	1.05e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.62e-06	1.05e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.62e-06	1.05e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.61e-06	1.04e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.61e-06	1.04e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.6e-06	1.04e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.6e-06	1.03e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—IL6—atherosclerosis	1.59e-06	1.03e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.59e-06	1.03e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.58e-06	1.03e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.58e-06	1.02e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—IL6—atherosclerosis	1.57e-06	1.02e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.57e-06	1.02e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.57e-06	1.02e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.56e-06	1.01e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.56e-06	1.01e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.56e-06	1.01e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.55e-06	1e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.54e-06	9.99e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.54e-06	9.99e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.54e-06	9.99e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.54e-06	9.98e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.54e-06	9.96e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.53e-06	9.89e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—AGT—atherosclerosis	1.5e-06	9.72e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—ALB—atherosclerosis	1.49e-06	9.66e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.47e-06	9.54e-06	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—AKT1—atherosclerosis	1.47e-06	9.52e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—APOE—atherosclerosis	1.47e-06	9.52e-06	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—AKT1—atherosclerosis	1.46e-06	9.47e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.46e-06	9.43e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.45e-06	9.41e-06	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—AKT1—atherosclerosis	1.45e-06	9.39e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.43e-06	9.26e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.43e-06	9.24e-06	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	1.42e-06	9.19e-06	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—AKT1—atherosclerosis	1.38e-06	8.94e-06	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.37e-06	8.87e-06	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.36e-06	8.83e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.33e-06	8.59e-06	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	1.33e-06	8.59e-06	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.31e-06	8.48e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.3e-06	8.45e-06	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.3e-06	8.45e-06	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—AKT1—atherosclerosis	1.29e-06	8.39e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.28e-06	8.29e-06	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.26e-06	8.19e-06	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	1.26e-06	8.15e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—INS—atherosclerosis	1.26e-06	8.13e-06	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.22e-06	7.92e-06	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.2e-06	7.8e-06	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IL6—atherosclerosis	1.2e-06	7.79e-06	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.19e-06	7.7e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IL6—atherosclerosis	1.18e-06	7.67e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.18e-06	7.65e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.18e-06	7.63e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.17e-06	7.6e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.16e-06	7.53e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.16e-06	7.51e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—ALB—atherosclerosis	1.15e-06	7.46e-06	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.11e-06	7.19e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.1e-06	7.13e-06	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.09e-06	7.07e-06	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.09e-06	7.07e-06	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.09e-06	7.06e-06	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.09e-06	7.04e-06	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.08e-06	7.01e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.08e-06	6.98e-06	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.07e-06	6.94e-06	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.07e-06	6.93e-06	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—AKT1—atherosclerosis	1.03e-06	6.66e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.01e-06	6.52e-06	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	9.93e-07	6.44e-06	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—AKT1—atherosclerosis	9.43e-07	6.11e-06	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—AKT1—atherosclerosis	8.42e-07	5.45e-06	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—AKT1—atherosclerosis	8.21e-07	5.32e-06	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—AKT1—atherosclerosis	7.74e-07	5.01e-06	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—AKT1—atherosclerosis	7.67e-07	4.97e-06	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—AKT1—atherosclerosis	6.56e-07	4.25e-06	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—AKT1—atherosclerosis	5.06e-07	3.28e-06	CbGpPWpGaD
